218 related articles for article (PubMed ID: 15986076)
1. Mycophenolate mofetil: a dermatologic perspective.
Mydlarski PR
Skin Therapy Lett; 2005 Apr; 10(3):1-6. PubMed ID: 15986076
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil in dermatology.
Orvis AK; Wesson SK; Breza TS; Church AA; Mitchell CL; Watkins SW
J Am Acad Dermatol; 2009 Feb; 60(2):183-99; quiz 200-2. PubMed ID: 19150270
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolic acid in dermatology a century after its discovery.
Strathie Page SJ; Tait CP
Australas J Dermatol; 2015 Feb; 56(1):77-83. PubMed ID: 25557632
[TBL] [Abstract][Full Text] [Related]
4. [Mycophenolate mofetil: a new immunosuppressive drug in dermatology and its possible uses].
Geilen CC; Orfanos-Boeckel H; Offermann G; Orfanos CE
Hautarzt; 2000 Feb; 51(2):63-9. PubMed ID: 10743574
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil.
Zwerner J; Fiorentino D
Dermatol Ther; 2007; 20(4):229-38. PubMed ID: 17970888
[TBL] [Abstract][Full Text] [Related]
6. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation.
Behrend M
Clin Nephrol; 1996 May; 45(5):336-41. PubMed ID: 8738667
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate in dermatology.
Liu V; Mackool BT
J Dermatolog Treat; 2003 Dec; 14(4):203-11. PubMed ID: 14660264
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease.
Larkin G; Lightman S
Ophthalmology; 1999 Feb; 106(2):370-4. PubMed ID: 9951492
[TBL] [Abstract][Full Text] [Related]
9. Phase I clinical trial of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil (cellcept) in advanced multiple myeloma patients.
Takebe N; Cheng X; Wu S; Bauer K; Goloubeva OG; Fenton RG; Heyman M; Rapoport AP; Badros A; Shaughnessy J; Ross D; Meisenberg B; Tricot G
Clin Cancer Res; 2004 Dec; 10(24):8301-8. PubMed ID: 15623606
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacological profiles of mycophenolate mofetil (CellCept), a new immunosuppressive agent].
Yashima Y; Ohgane T
Nihon Yakurigaku Zasshi; 2001 Feb; 117(2):131-7. PubMed ID: 11233304
[TBL] [Abstract][Full Text] [Related]
11. Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses.
Kitchin JE; Pomeranz MK; Pak G; Washenik K; Shupack JL
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):445-9. PubMed ID: 9308561
[TBL] [Abstract][Full Text] [Related]
12. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
Allison AC; Eugui EM
Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacology of mycophenolate mofetil: recent data and clinical consequences].
Thervet E; Anglicheau D; Legendre C
Nephrologie; 2001; 22(7):331-7. PubMed ID: 11817210
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic monitoring of mycophenolate mofetil.
Budde K; Glander P; Bauer S; Braun K; Waiser J; Fritsche L; Mai I; Roots I; Neumayer HH
Clin Chem Lab Med; 2000 Nov; 38(11):1213-6. PubMed ID: 11156363
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil--clinical and experimental experience.
Pirsch JD; Sollinger HW
Ther Drug Monit; 1996 Aug; 18(4):357-61. PubMed ID: 8857550
[TBL] [Abstract][Full Text] [Related]
16. Indications of mycophenolate mofetil in liver transplantation.
Klupp J; Pfitzmann R; Langrehr JM; Neuhaus P
Transplantation; 2005 Sep; 80(1 Suppl):S142-6. PubMed ID: 16286893
[TBL] [Abstract][Full Text] [Related]
17. [Mycophenolate mofetil--20 years of experience in treatment of rheumatic diseases].
Walkiewicz-Pielaszek K; Swacha M; Bułło-Piontecka B; Rutkowski B; Olesiñska M
Postepy Hig Med Dosw (Online); 2015 Feb; 69():176-87. PubMed ID: 25661917
[TBL] [Abstract][Full Text] [Related]
18. From mechanisms to long-term benefits.
Mamelok R
Transplantation; 2005 Feb; 79(3 Suppl):S43-4. PubMed ID: 15699749
[TBL] [Abstract][Full Text] [Related]
19. Induction of inosine monophosphate dehydrogenase activity after long-term treatment with mycophenolate mofetil.
Sanquer S; Breil M; Baron C; Dhamane D; Astier A; Lang P
Clin Pharmacol Ther; 1999 Jun; 65(6):640-8. PubMed ID: 10391669
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients.
Siepmann K; Huber M; Stübiger N; Deuter C; Zierhut M
Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):788-94. PubMed ID: 16163494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
